In MPN, JAK2V617F increases phosphorylation of STAT3 and STAT5 to promote PD-L1 expression mainly on the surfaces of monocytes, MDSCs, megakaryocytes and platelets [317]. Here, STAT5A is linked to myeloproliferative disorder.